CST2 and neoplasm: In gastric cancer samples, CST2 is upregulated, enhancing tumor cell growth, migration, and invasion by regulating epithelial-mesenchymal transition (EMT) and the TGF-β1 signaling pathway, leading to poor prognosis in patients (9).